missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BRK Polyclonal Antibody

Description
Immunogen sequence: IRVSEKPSAD YVLSVRDTQA VRHYKIWRRA GGRLHLNEAV SFLSLPELVN YHRAQSLSHG LRLAAPCRKH EPEPLPHWDD WE Highest antigen sequence indentity to the following orthologs: Mouse - 76%, Rat - 70%.
Breast tumor kinase (Brk) is a non-receptor protein tyrosine kinase expressed in over 60% of breast carcinoma tissue samples and breast tumor cell lines. Brk is 80% identity to Sik (Src-related intestinal kinase) and exhibits the features of a novel non-receptor tyrosine kinase, including amino terminal SH3 and SH2 domains. Low levels of Brk transcripts have been identified in some human breast tumor cell lines but not in normal breast tissue.
Specifications
Specifications
| Antigen | BRK |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 0.3 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | PTK6 |
| Gene Accession No. | Q13882 |
| Gene Alias | ALT-PTK6; breast tumor kinase; BRK; deltam5; FLJ42088; protein tyrosine kinase 6; protein-tyrosine kinase 6; protein-tyrosine kinase BRK; Ptk6; PTK6 protein tyrosine kinase 6; Sik; SRC-related intestinal kinase; tks; Tksk; tyrosine kinase identified from skin; tyrosine-protein kinase BRK |
| Gene Symbols | PTK6 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?